Literature DB >> 21849702

Phosphate and CVD: it's all in what's on the table.

Gary E Striker, Fabrizio Grosjean, Helen Vlassara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21849702      PMCID： PMC3704162          DOI： 10.1161/ATVBAHA.111.231928

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  22 in total

1.  Dietary phosphate modulates atherogenesis and insulin resistance in apolipoprotein E knockout mice--brief report.

Authors:  Timothy Ellam; Martin Wilkie; Janet Chamberlain; David Crossman; Richard Eastell; Sheila Francis; Timothy J A Chico
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

Review 2.  Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty; Rajesh Garg
Journal:  Circulation       Date:  2005-03-22       Impact factor: 29.690

Review 3.  Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

Authors:  Earl S Ford
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

4.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

Review 5.  AGE restriction in diabetes mellitus: a paradigm shift.

Authors:  Helen Vlassara; Gary E Striker
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

6.  Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

Authors:  Marcello Tonelli; Frank Sacks; Marc Pfeffer; Zhiwei Gao; Gary Curhan
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

7.  Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study.

Authors:  Mark A Pereira; David R Jacobs; Linda Van Horn; Martha L Slattery; Alex I Kartashov; David S Ludwig
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

Review 8.  Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.

Authors:  Karen S Meir; Eran Leitersdorf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-15       Impact factor: 8.311

9.  Effects of hypophosphatemia on glucose tolerance and insulin secretion.

Authors:  F J Paula; A E Plens; M C Foss
Journal:  Horm Metab Res       Date:  1998-05       Impact factor: 2.936

10.  Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.

Authors:  Jaime Uribarri; Weijing Cai; Maya Ramdas; Susan Goodman; Renata Pyzik; Xue Chen; Li Zhu; Gary E Striker; Helen Vlassara
Journal:  Diabetes Care       Date:  2011-07       Impact factor: 19.112
View more
  1 in total

1.  Cisplatin nephrotoxicity as a model of chronic kidney disease.

Authors:  Mingjun Shi; Kathryn L McMillan; Junxia Wu; Nancy Gillings; Brianna Flores; Orson W Moe; Ming Chang Hu
Journal:  Lab Invest       Date:  2018-06-01       Impact factor: 5.662
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.